Search

Your search keyword '"Sanson, M."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Sanson, M." Remove constraint Author: "Sanson, M." Publication Type Magazines Remove constraint Publication Type: Magazines
36 results on '"Sanson, M."'

Search Results

1. Abstracts

2. IDH1or IDH2mutations predict longer survival and response to temozolomide in low-grade gliomas

3. All the 1p19q codeleted gliomas are mutated on IDH1or IDH2(e–Pub ahead of print)

4. Supratentorial low-grade gliomas in older patientsSYMBOL

5. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri

6. Bevacizumab and irinotecan for recurrent oligodendroglial tumors

7. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma

8. -Internexin expression identifies 1p19q codeleted gliomasSYMBOL

9. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri

10. Temozolomide for low-grade gliomas

11. Méningiomes et progestatifs

12. Initial chemotherapy in gliomatosis cerebri

13. Neuro-oncogenesis: an update

14. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions.

16. Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study

18. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain

20. Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79

21. Performances Diagnostiques de la Séquence ASL pour Évaluer le Reliquat Post-Opératoire Immédiat des Tumeurs Cérébrales Primitives et Secondaires

22. Polymorphism in Sp1 recognition site of the EGFreceptor gene promoter and risk of glioblastoma

24. Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1

25. P18tumor suppressor gene and progression of oligodendrogliomas to anaplasia

26. Dysthyroïdies sous thérapies ciblées anti-PD1

27. Dysthyroïdies sous thérapies ciblées anti-PD1

28. EGFR tyrosine kinase domain mutations in human gliomas

30. Méningiomes multi-récidivants : établissement de critères de réponse thérapeutiques après analyse des cinétiques de croissance et des types de récidive

33. Temozolomide for low-grade gliomas

34. Glioblastomas with an Oligodendroglial Component: A pathological and Molecular Study

Catalog

Books, media, physical & digital resources